Search

The U.S. multinational BioIVT, a global leader in the development of high-quality biological samples and research services for drug and diagnostic development, has acquired the Catalan company BeCytes

The development of novel biomarkers represents one of the most challenging frontiers in biotechnology, requiring the orchestration of multiple scientific, technical, regulatory and managerial

Biotechnology is rapidly transforming the pharmaceutical landscape—yet its industrialisation presents challenges that require coordinated technical, regulatory and strategic action.

New Product Launches: Custom Cell Plates & Shipping Media

BCN HEALTH conducted a retrospective study using records of patients diagnosed with osteogenesis imperfecta who were treated in public and private hospitals in Spain between 2000 and 2017.

The company has achieved a 14.44% reduction in the average emission intensity for the 2022–2024 period compared to 2021–2023, for scopes 1+2

Biohope, a Spanish company specialized in personalized medicine solutions for transplant and autoimmune patients, has signed a know-how agreement with Mayo Clinic, a global leader in medical research

Among the most notable milestones are the sponsorship of the first edition of the Pharmacovigilance Forum, which featured the participation of the AEMPS (Spanish Agency of Medicines and Medical

100% Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients

The study will be conducted in the Intensive Care Medicine Service of the Vall d’Hebron University Hospital, led by Dr. Ricard Ferrer, an international leader in sepsis.

Integra Therapeutics strengthens its corporate governance with the appointment of Miles Gerson as Independent Chair of its Board of Directors. With more than two decades of experience in investment

A public-private consortium led by the biotechnology company Nuage Therapeutics, together with the Spanish National Cancer Research Center (CNIO), the European Molecular Biology Laboratory (EMBL) and

The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New Genomic Techniques (NGTs) and the food and feed derived from them.

Meet BePharma Institute, our new memeber. We spoke with Pedro Gonzáles Sánchez, manager.

Meet Neural Omega, our new member. We spoke with Pedro Bernardo Martín-Borregon, Founder & CEO.

Joan Puig, a graduate in Pharmacy and in Business Administration and Management, and with a General Management Programme (PDG) from IESE, has an extensive background in the field of analytical and